Filing Details

Accession Number:
0001008310-12-000012
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-08 18:28:02
Reporting Period:
2012-03-07
Filing Date:
2012-03-08
Accepted Time:
2012-03-08 18:28:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899923 Myriad Genetics Inc MYGN In Vitro & In Vivo Diagnostic Substances (2835) 870494517
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1008310 D Peter Meldrum 320 Wakara Way
Salt Lake City UT 84108
President & C.e.o. Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-03-08 7,296 $3.80 188,197 No 4 M Direct
Common Stock Disposition 2012-03-08 7,296 $24.50 180,901 No 4 S Direct
Common Stock Acquisiton 2012-03-08 10,000 $8.68 190,901 No 4 M Direct
Common Stock Disposition 2012-03-08 10,000 $24.52 180,901 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Acquisiton 2012-03-07 4,170 $0.00 4,170 $23.98
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-03-08 7,296 $0.00 7,296 $3.80
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-03-08 10,000 $0.00 10,000 $8.68
Common Stock Non-Qualified Stock Option (right to buy) Acquisiton 2012-03-07 99,830 $0.00 99,830 $23.98
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,170 2022-03-07 No 4 A Direct
0 2013-02-13 No 4 M Direct
40,000 2012-08-16 No 4 M Direct
99,830 2022-03-07 No 4 A Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan.
  2. The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.